Grape King Bio Ltd (葡萄王), a supplier of probiotics and mushroom mycelium health foods, yesterday inked a three-year cooperation pact with China-based traditional Chinese medicine maker Yunnan Baiyao Group Co (雲南白藥) to codevelop new products and sell products in the Chinese and Southeast Asian markets.
The two companies are currently codeveloping two healthy drink products, one ointment and one pill, Grape King Bio said.
The two companies will jointly launch a health drink in Taiwan at the end of September, ahead of future launches in China and SouthEast Asia next year, Grape King Bio executive vice president Andrew Tseng (曾盛麟) said yesterday.
The company has the rights to sell products codeveloped by both in Taiwan, he said.
Yesterday’s deal also allows Grape King Bio to manufacture products for Yunnan Baiyao Group on a contract basis, while using raw materials provided by the Chinese firm in the new products.
The company will use its factories in Taiwan and Shanghai to make products for Yunnan Baiyao Group, he said.
Meanwhile, Grape King Bio can rely on Yunnan Baiyao Group’s retail channels in China and other oversea markets, including Southeast Asia, to sell its health food products that use raw materials from Yunnan Baiyao Group, Tseng said.
“As most of our revenue currently comes from the domestic market, the deal marks the entrance for Grape King Bio into the international market,” Tseng said.
According to Tseng, Grape King Bio tried to sell its “Come Best” tonic drink, products for improving digestion and mushroom mycelium health foods in China in the past without much success because it lacked a retail network.
The cooperation with Yunnan Baiyao Group may enable the company to enter the market more easily, he said.
Yunnan Baiyao Group is a Shenzhen-listed company with revenue of 15.8 billion yuan (US$2.54 billion) last year, and its market value, which was 82.8 billion yuan in October last year, was the highest among all Chinese medicine makers.
“It is the first time for Yunnan Baiyao Group to sign such a comprehensive cooperation pact with another company,” Tseng said.
From January through May, Grape King Bio posted revenue of NT$2.47 billion (US$82.52 million), up 8.34 percent from NT$2.28 billion a year ago, according to the company’s filing to the Taiwan Stock Exchange.
About 90 percent of its revenue was from Pro-Partner Inc (葡眾), a multi-level marketing company which sells Grape King Bio’s products in Taiwan, Tseng said.
Grape King Bio owns 60 percent of shares of Pro-Partner.
“It is a little bit risky for us to rely on Pro-Partner entirely,” Tseng said. “The cooperation with Yunnan Baiyao Group can become the second pilar of Grape King Bio.”
Shares of Grape King Bio rose 4.93 percent to NT$149 yesterday, outperforming the TAIEX, which was up 0.44 percent.
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the
GLOBAL ECONOMY: Policymakers have a choice of a small 25 basis-point cut or a bold cut of 50 basis points, which would help the labor market, but might reignite inflation The US Federal Reserve is gearing up to announce its first interest rate cut in more than four years on Wednesday, with policymakers expected to debate how big a move to make less than two months before the US presidential election. Senior officials at the US central bank including Fed Chairman Jerome Powell have in recent weeks indicated that a rate cut is coming this month, as inflation eases toward the bank’s long-term target of two percent, and the labor market continues to cool. The Fed, which has a dual mandate from the US Congress to act independently to ensure